摘要:
The use of levo-ornidazole in the preparation of medicine for preventing and treating the anti-anaerobic bacteria infection is provided. It is demonstrated that levo-ornidazole exhibits lower toxicity and less central inhibition effects than dextro-ornidazole or racemic ornidazole. L-ornidazole possesses pharmacokinetics characteristics, which are superior to that of the racemic ornidazole, and anti-anaerobic activities which are slightly better than or substantially the same as that of the racemic ornidazole. Also, this invention particularly relates to a preparation process, which comprises formulating L-ornidazole as anti-anaerobic infection pharmaceutical preparations, which are suitable for clinical uses.
摘要:
A novel immunosuppressive agent, more specifically an immunosuppressive agent comprising, as an active ingredient, a heterocyclic compound represented by the general formula (I) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof; a novel heterocyclic compound represented by the general formula (II) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof; and use of the compound or salt as an antitumor agent.
摘要:
A remote charging system (200) includes a power transmission unit (20), which transmits a wireless energy signal (10) as a plurality of constructive transmitted frequencies (11A, 11B), and a power receiver unit (44) that receives the transmitted frequencies (11A, 11B). The power receiver unit (44) is preferably incorporated in a device (40) and includes an energy receptor capable of receiving the wireless transmitted energy signal (10) and transferring the energy from the transmitted frequencies (11A, 11B) to an energy storage device included in the device.
摘要:
The present invention provides systems, methods and kits for performing multiplexed assays for glycoproteins using encoded particles as supports for glycoprotein specific binding agents.
摘要:
The methane sulphonate salt of morphine and compositions thereof are described. Also described is a composition adapted for nasal delivery comprising a methane sulphonate salt of an opioid analgesic.
摘要:
A compound or a mixture of compounds comprising an aromachemical compound of I the formula: NC-CH2-O-R wherein: R is straight or branched chain alkyl, alkenyl having 1-16 carbon atoms, aryl, aralkyl, alkaryl, thiophenyl or substituted derivatives thereof as well as compositions, products, preparations or articles having improved aroma, fragrance or odor characteristics containing as active ingredient such compound or mixture of compounds.
摘要:
The invention provides a controlled release soft capsule having a shell and a matrix fill comprising an active ingredient or drug, wherein the matrix fill comprises two phases in the form of an emulsion.
摘要:
A film-forming composition comprising a hydrocolloid, a plasticizer, and water is described. A process and apparatus for producing a non-gelatin film comprising a hydrocolloid, a plasticizer, and water is also disclosed. The process includes combining at least one non-gelatin hydrocolloid, water, and at least one plasticizer into a substantially homogeneous film-forming composition comprising at least about 40 percent water by weight. A substantial portion of the water is then extracted from the film-forming composition to form a dried portion having a water content of less than or equal to about 25 percent by weight. The dried portion of the film-forming composition is formed into a film. A film produced according to the process preferably has a tensile strength at rupture of at least about 5 N, and a percent elongation of at least about 50 percent at rupture at room temperature. An apparatus for performing the process is also described, as well oral dosage forms encapsulated or enrobed in the produced film.
摘要:
This inventiori provides a method of performing fluorescence correlation spectroscope which comprises acquiring a fluorescence measurement from a sample over time to obtain a histogram of photon counts; deriving the molecular brightness of at least one molecular species in the sample; and determining the concentration of the species.
摘要:
A process for the decomposition and removal of one or more fluorine containing compounds from a first gaseous mixture comprising the one or more fluorine containing compounds and water vapour, which process comprises the stages of: (i) contacting the first gaseous mixture with a catalyst comprising an aluminium based material to produce a second gaseous mixture comprising hydrogen fluoride and carbon oxides; and (ii) removing the hydrogen fluoride from the second gaseous mixture to produce a third gaseous mixture, which is substantially free of hydrogen fluoride.